NCT03317743: A Study of NOV140101(IDX1197HCl) in Subject With Advanced Solid Tumors

NCT03317743
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Ph+ase 1
Drug Category: Misc Inhibitor

Key Eligibility Criteria:

Gender: All
Age: 19 Years and older (Adult, Senior)
Location of Metastases: 
Additional Notes: 
Exclusions: Symptomatic or uncontrolled central nervous system (CNS) metastasis
https://ClinicalTrials.gov/show/NCT03317743

Comments are closed.

Up ↑